New Product: Alphanate 2000 IU powder for injection (factor VIII von willebrand factor)

Product is licensed for treatment and prophylaxis of bleeding in patients with haemophilia A, von Willebrand disease (when desmopressin treatment alone is ineffective or contra-indicated) & for management of acquired factor VIII deficiency.

Source:

electronic Medicines compendium